Pyridostigmine bromide
NDC 60846-559, Pyridostigmine bromide, tablet, extended release, from Amneal Pharmaceuticals LLC.
- Product NDC
- 60846-559
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217604
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60846-559 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PYRIDOSTIGMINE BROMIDE105 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60846-559-10 | 60846055910 | 10 CARTON in 1 BAG (60846-559-10) / 1 BLISTER PACK in 1 CARTON (60846-559-27) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/52d6f195-165a-400b-a13b-489e94bcf0b0
Use it
Look up 60846-559 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60846-559 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60846-559. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.